Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
ACADIA Pharmaceuticals
Sort By
Newest First
Sign in
1 / 1
1 / 1
Clinical Results
ACADIA Pharmaceuticals Presents Positive Top-line Results from Dementia-Related Psychosis Trial
Acadia Pharmaceuticals
PR-M12-19-NI-012
Dec 06, 2019
Clinical Trial
Arial Halts Trial for First Drug to Treat DRP Early
Nice Insight
PAO-M09-19-NI-015
Sep 20, 2019
Clinical Trials
ACADIA Pharmaceuticals Announces Meets the Primary Phase 3 Endpoint in Patients with Dementia-Related Psychosis
Acadia Pharmaceuticals
PR-M09-19-NI-036
Sep 13, 2019
License Agreement
ACADIA Pharmaceuticals and Neuren Pharmaceuticals Announce Exclusive License Agreement for the North American Development and Commercialization of Trofinetide in Rett Syndrome
Acadia Pharmaceuticals
PR-M08-18-NI-071
Aug 16, 2018
